Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures FTSE +0.36%, DAX +0.48%, CAC40 +0.96%

Mar 04 ,2026

  • Synopsis

    • European equity market futures point to a positive open. Asia equities steeply down for a third day Wednesday as risk-off sentiment dominates again. South Korea's Kospi underperforming for a second day with 8% losses first thing triggering a trading halt but is down again post resumption of business. Nikkei and Topix near 4% lower, Hang Seng sharply down and mainland China boards also losing ground. US futures paring early advances, now suggesting more losses at the open.

    • Iran war a key driver of market sentiment with most of the focus on energy disruptions amid inoperability of Strait of Hormuz, and Iranian attacks against Middle East energy facilities. Trump said US will aid tanker traffic through Hormuz via insurance support and naval escorts, but questions around implementation remain. Qatar LNG plant also remains closed, fueling another sharp rise in LNG prices while playing into broader concerns about a supply shock that stokes inflationary pressures.

    • Back in Europe, UK weekly PMQs begins at 12noon GMT whilst committee topics include supercharging the EV transition at 9:15, GB Energy and the net zero transition at 9:30, growth and proposed regulation of stablecoins in the UK at 10:00, financial inclusion strategy at 14:15 (includes execs from Allianz UK, Lloyds Banking Group, Nationwide) and the cost of energy at 15:00 (includes execs from regulator Ofgem as well as National Energy System Operator (NESO)). EU's Kallas attends the Council of the Baltic Sea States foreign ministerial meeting and delivers 'Churchill Lecture' at the Univ. of Zurich whilst EU's Hoekstra speaks at annual EU Energy Summit. Ukraine and Russia may have another round of talks under the mediation of the US.

    • In central banks, Riksbank publishes at 9:30CET new recommendations to the public on how they can strengthen their readiness to pay even in the event of temporary disruptions, crises and wars. Estonia central bank's Müller panellist at 11:40CET at Kite Flight conf. The OECD will release the Global Debt Report 2026: Sustaining Debt Market Resilience Under Growing Pressure at 13:00 CET, with Bank of France's Villeroy speech at related conf at 13:40. Bundesbank's Balz panellist at 18:00CET at event hosted by the bank. Poland central bank announces interest rate decision at 15:00CET with a (25bps) cut to 3.75% expected. EIB Group Forum speakers include European Council President Costa at 9:30CET and Eurogroup President Pierrakakis at 11:30.

    • On the macro front, Italy, Spain, Sweden Feb services PMI as well as final reads for Eurozone, France, Germany, UK, Switzerland Feb CPI, Italy Jan unemployment rate, Italy Q4 GDP, Eurozone Jan PPI, unemployment rate, Ireland Feb unemployment rate and Austria Q4 final GDP.

    • In earnings, ASM International (ASM.NA) confirmed prelim Q4 earnings and announced a new €150M buyback. In the DACHs region, Bayer (BAYN.GR) reported Q4 core EPS €0.62 (cont ops) vs consensus €0.48 whilst Adidas (ADS.GR) reported Q4 net income from continuing operations €85M vs FactSet €78.2M with share buybacks worth up to €1B in both 2027 and 2028. Symrise (SY1.GR) reported FY EPS €3.67 vs consensus €3.28, Continental (CON.GR) confirmed prelim FY25 earnings as per 21-Jan update and TRATON (8TRA.GR) reported FY revenue €44.05B vs FactSet €43.69B. Also out with earnings are Evonik Industries (EVK.GR), Sixt (SIX2.GR), Bilfinger (GBF.GR) and SCOR (SCR.FP) whilst FinecoBank (FBK.IM) approved its 2026-29 industrial plan at its CMD.

    • Of note, pricing of Gabler Group (XK4.GR) IPO and next scheduled index review of the DAX index family.

  • Politics/Macro/World News

    • US reportedly weighing tanker insurance support to ease Mideast oil shipments -- Reuters

    • Trump says US DFC to provide insurance for maritime trade traveling through Gulf, Navy to escort tankers if necessary-- Truth Social post

  • Top company news

    • Earnings/updates

      • Benelux:

        • ASM.NA (ASM International) -- confirms prelim Q4 earnings as per 19-Jan update; announces divi and new €150M buyback; guides Q1 and Q2

      • DACHs:

        • BAYN.GR (Bayer) -- reports Q4 core EPS €0.62 (cont ops) vs consensus €0.48

        • ADS.GR (Adidas) -- reports Q4 net income from continuing operations €85M vs FactSet €78.2M; proposes dividend +40% to € 2.80/sh; authorizes additional share buybacks worth up to € 1B in both 2027 and 2028

        • SY1.GR (Symrise) -- reports FY EPS €3.67 vs consensus €3.28; targets FY26 adj. EBITDA margin of 21.5-22.5%

        • SIX2.GR (Sixt) -- reports FY EPS €6.09 vs FactSet €6.24 [9 est, €6.06-6.44]

        • CON.GR (Continental) -- confirms prelim FY25 earnings as per 21-Jan update; hikes divi by 8% and guides FY26 (

        • 8TRA.GR (TRATON) -- reports FY revenue €44.05B vs FactSet €43.69B [21 est, €42.11-44.61B]

        • EVK.GR (Evonik Industries) -- confirms prelim Q4/FY25 results and FY26 outlook as per 5-Feb update

        • GBF.GR (Bilfinger) -- reports Q4 EPS €1.14 vs FactSet €1.58 (unclear if comparable)

        • RDC.GR (Redcare Pharmacy) -- reports Q4 adjusted EBITDA €13.1M vs FactSet €17.1M [3 est, €14-20.5M]

        • EAPI.FP (Euroapi) -- reports FY net income (€211.2M) vs year-ago (€130.6M)

        • AT1.GR (Aroundtown) -- reports FY FFO I €0.26 vs guidance €0.26-0.28 and FactSet €0.27

        • GYC.GR (Grand City Properties) -- reports FY FFO 1 €1.06 vs guidance €1.05-1.11 and FactSet €1.07

        • IMPN.SW (Implenia) -- reports FY net income CHF84.7M vs FactSet CHF86.3M [5 est, CHF83.1-88.6M]

      • France:

        • TRACT.FP (Teract) -- reports H1 net income (€89.4M) including items vs year-ago (€38.1M)

        • SCR.FP (SCOR) -- reports Q4 net income €208M vs consensus €170M; Proposed regular DPS of €1.9 vs consensus €1.9

      • Nordics:

        • BWO.NO (BW Offshore) -- releases company presentation in connection with DNB Carnegie Energy & Shipping Conf

      • Southern Europe:

        • FBK.IM (FinecoBank) -- approves 2026-29 industrial plan - CMD

        • NOS.PL (NOS SGPS) -- reports Q4 net income €63.8M vs FactSet €30.2M [3 est, €21.6-43.9M]

    • M&A

      • NESN.SW (Nestle) -- Centurium Capital enters agreement to buy Blue Bottle from Nestle; terms unreported - Late Post

      • BNJ.NA (Banijay Group) -- announces combination of Banijay Entertainment and All3Media

      • TEVA (Teva Pharmaceutical) -- Teva and Blackstone Life Sciences to advance duvakitug through $400M strategic growth capital agreement

      • DOKA.SW (dormakaba Holding) -- acquires remaining shares of any2any; terms undisclosed

      • GYC.GR (Grand City Properties) -- Aroundtown puts forward offer to acquire up to 47.5M-shares of Grand City Properties

      • GYC.GR (Grand City Properties) -- reports FY FFO 1 €1.06 vs guidance €1.05-1.11 and FactSet €1.07

      • CIE.SM (CIE Automotive) -- announces completion of acquisition of the Aludec Group

      • EYDAP.GA GEK Terna acquires a 9.71% stake in Athens Water Supply & Sewage Co. for a total consideration of €103.4M

      • Partners Group considering bid for Infinity Pharmacy Group - Australian Financial Review

    • Healthcare

      • SAN.FP (Sanofi) -- Transcript Intelligence: Sanofi at TD Cowen Health Care Conference

      • 1177.HK (Sino Biopharmaceutical) -- Chia Tai Tianqing Pharmaceutical enters into an exclusive license agreement with Sanofi subsidiary for global development, manufacturing and commercialization of rovadicitinib

      • 532296.IN (Glenmark Pharmaceuticals) -- FDA approves Glenmark's fluticasone propionate inhalation aerosol; first generic of GSK's Flovent HFA

    • Other

      • NKT.DC (NKT) -- signs record order for power cable project Eastern Green Link 3 reinforcing the UK power grid

      • ADS.GR (Adidas) -- Supervisory Board to propose re-election of Nassef Sawiris to succeed Thomas Rabe as Chairman

      • NHY.NO (Norsk Hydro) -- announces Qatalum initiates controlled shutdown of aluminium production

      • DEC.FP (JCDecaux) -- awarded 10-year advertising contract at Denver International Airport (DEN)

      • DIE.BB (D'Ieteren Group) -- appoints Rothschild as it explores strategic options for controlling stake in Belron - Bloomberg

      • CO.FP (Casino Guichard-Perrachon) -- Casino Group provides update related to arbitration with GPA

      • SUBC.NO (Subsea 7) -- CEO John Evans to retire, effective 30-Jun

      • EQT.SS (EQT AB) -- approves sharebuyback of a maximum of ~3.0M own ordinary shares

      • R3NK.GR (Renk Group) -- US Defense Logistics Agency awards Renk America $57.6M (€49.7M) contract for diesel engines

      • Rio Tinto, Western Australian Government enter into 50:50 JV to complete both Stage 1 and Stage 2 of Dampier Seawater Desalination Plant

      • US considers protection for oil, gas tankers in Hormuz; NY wins challenge to congestion pricing in intraday themes (3-Mar-26)

  • Key rating changes

    • Upgrades

      • KGX.GR (Kion Group) -- hold from underperform at Jefferies

      • AKBM.NO (Aker BioMarine) -- buy from hold at DNB Carnegie

      • AC.FP (Accor) -- to buy from hold at Kepler Cheuvreux

      • AMG.NA (AMG Critical Materials) -- to buy from hold at Deutsche Bank

      • BN.FP (Danone) -- to outperform from neutral at BNP Paribas Exane

      • TEMN.SW (Temenos) -- Temenos transferred overweight at Barclays; prior rating was equal weight

      • ZURN.SW (Zurich Insurance Group) -- to buy from neutral at Intesa Sanpaolo

    • Downgrades

      • DSY.FP (Dassault Systemes) -- to neutral from buy at Goldman Sachs

      • KNIN.SW (Kuehne & Nagel) -- to reduce from hold at HSBC

      • HO.FP (Thales) -- to neutral from overweight at JPMorgan

      • SGRO.LN (Segro) -- to neutral from buy at UBS

      • SYENS.BB (Syensqo) -- to neutral from buy at UBS

      • BWLPG.NO (BW LPG) -- to hold from buy at Arctic Securities

      • PHO.NO (PhotoCure) -- to hold from buy at ABG Sundal Collier

    • Other Actions

      • COLO.B.DC (Coloplast) -- transferred hold at Deutsche Bank; prior rating was hold

  • Data

    • Nikkei (3.61%) to 54245.54

    • Hang Seng (2.49%) to 25126.65

    • Shanghai Composite (0.82%) to 4088.94

    • S&P futures (34.3) vs prior close of 6824.8

    • €-$ +0.0002 or +0.02% to 1.1615

    • $-¥ (0.34) or (0.22%) to 157.40

    • €-¥ (0.39) or (0.21%) to 182.79

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.